STOCK TITAN

Werewolf Therapeutics, Inc. (HOWL) Debt by Year

HOWL

Werewolf Therapeutics, Inc. carried $32.1M in long-term debt against $57.0M in cash and equivalents at the end of fiscal year 2025. That is unchanged from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Werewolf Therapeutics, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $32.1M
Cash & Equivalents $57.0M
YoY 0.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HOWL Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Long-Term Debt$32.1M0.0%$32.1M-19.8%$40.0MN/AN/AN/A
Cash & Equivalents$57.0M-48.6%$111.0M-17.4%$134.3M+3.9%$129.3M-17.9%$157.5M+70.2%$92.6M

HOWL Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'26S-4Q1'26S-4Q4'25S-4Q3'2510-QQ2'25S-4Q1'25S-4Q4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term DebtN/A$32.1M0.0%$32.1M0.0%$32.1M0.0%$32.1M0.0%$32.1M-19.8%$32.1M-19.8%$32.1M$32.1M$40.0M$40.0MN/A
Cash & Equivalents$22.0M-71.7%$46.5M-49.5%$57.0M-48.6%$65.7M-46.5%$77.6M-42.7%$92.0M-33.9%$111.0M-17.4%$122.8M-5.6%$135.3M-1.6%$139.2M-5.9%$134.3M+3.9%$130.1M-7.4%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Werewolf Therapeutics, Inc. financials

Frequently Asked Questions

What was Werewolf Therapeutics, Inc.'s long-term debt in fiscal year 2025?

Werewolf Therapeutics, Inc. carried $32.1M in long-term debt against $57.0M in cash and equivalents at the end of fiscal year 2025.

How fast is Werewolf Therapeutics, Inc.'s long-term debt growing?

Werewolf Therapeutics, Inc. (HOWL) long-term debt was essentially unchanged year over year, at $32.1M in fiscal year 2025 against $32.1M the year before.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Werewolf Therapeutics, Inc. (HOWL) reported on that line in every period on record.